Usha Martin Limited has informed the Exchange about Investor Presentation
USHAMART · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Usha Martin reported FY25 revenue of Rs. 3,474 crore, up 7.7% year-on-year, driven by a 9.5% rise in sales volumes across core segments. Q4 FY25 revenue grew 8.1% YoY to Rs. 896 crore, but operating EBITDA margin contracted to 15.6% (from 18.3%) on a higher mix of lower-margin LRPC products. Full-year PAT fell 4.2% to Rs. 406 crore, and ROCE dropped to 19.3% from 22.8%. The company delivered strong cash flows, with operating cash flow at Rs. 541 crore (91% of EBITDA) and free cash flow of Rs. 177 crore, even after Rs. 245 crore of capex. Net debt fell sharply to Rs. 63 crore, and India Ratings upgraded its long-term rating to IND A+/Stable.
Margin pressure in the near term due to product mix is a concern, but a debt-free-ish balance sheet, strong cash generation, and management's confidence that 'One Usha Martin' cost initiatives will intensify from H2 FY26 provide a supportive setup for investors. Watch for execution on margin recovery in coming quarters.